In re Gabapentin Patent Litigation, MDL Docket No. 1384; U.S. District Court (DNJ); opinion by Hochberg, U.S.D.J.; filed May 12, 2011. DDS No. 53-7-2162 [35 pp.]

Plaintiffs bring claims for infringement of U.S. Patent No. 6,054,482, titled “Lactam-Free Amino Acids” (the ’482 patent). The ’482 patent discloses the manufacturing process for a substantially lactam-free form of gabapentin. Before the court are the 16 motions in limine filed by the parties.